Marzia Palma

1.5k total citations
49 papers, 1.1k citations indexed

About

Marzia Palma is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Marzia Palma has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 28 papers in Genetics and 15 papers in Oncology. Recurrent topics in Marzia Palma's work include Chronic Lymphocytic Leukemia Research (27 papers), Lymphoma Diagnosis and Treatment (14 papers) and Immunodeficiency and Autoimmune Disorders (13 papers). Marzia Palma is often cited by papers focused on Chronic Lymphocytic Leukemia Research (27 papers), Lymphoma Diagnosis and Treatment (14 papers) and Immunodeficiency and Autoimmune Disorders (13 papers). Marzia Palma collaborates with scholars based in Sweden, Italy and Iran. Marzia Palma's co-authors include Anders Österborg, Håkan Mellstedt, Lotta Hansson, Parviz Kokhaei, Aniruddha Choudhury, Alberto Gulino, Barbro Näsman‐Glaser, Fariba Mozaffari, Edoardo Alesse and Björn E. Wahlin and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Marzia Palma

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marzia Palma Sweden 18 549 521 366 292 244 49 1.1k
Paula Fukushima United States 13 367 0.7× 474 0.9× 119 0.3× 319 1.1× 187 0.8× 17 1.1k
Michele Bianchini Argentina 19 432 0.8× 421 0.8× 159 0.4× 425 1.5× 86 0.4× 45 1.2k
Antonis Dagklis Italy 15 411 0.7× 150 0.3× 511 1.4× 230 0.8× 443 1.8× 25 866
Kourong Miao China 17 248 0.5× 260 0.5× 342 0.9× 560 1.9× 197 0.8× 79 1.1k
Lindsey K. Goff United Kingdom 17 565 1.0× 466 0.9× 261 0.7× 385 1.3× 502 2.1× 32 1.2k
Cristiana Carniti Italy 21 314 0.6× 439 0.8× 169 0.5× 396 1.4× 245 1.0× 59 1.2k
Karin Badel United States 14 623 1.1× 766 1.5× 203 0.6× 296 1.0× 110 0.5× 27 1.6k
Yvona Brychtová Czechia 19 385 0.7× 294 0.6× 704 1.9× 422 1.4× 450 1.8× 71 1.2k
Ana Pilar González Spain 17 491 0.9× 524 1.0× 258 0.7× 164 0.6× 286 1.2× 45 1.0k
Siddha Kasar United States 14 342 0.6× 170 0.3× 522 1.4× 448 1.5× 351 1.4× 34 1.0k

Countries citing papers authored by Marzia Palma

Since Specialization
Citations

This map shows the geographic impact of Marzia Palma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marzia Palma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marzia Palma more than expected).

Fields of papers citing papers by Marzia Palma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marzia Palma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marzia Palma. The network helps show where Marzia Palma may publish in the future.

Co-authorship network of co-authors of Marzia Palma

This figure shows the co-authorship network connecting the top 25 collaborators of Marzia Palma. A scholar is included among the top collaborators of Marzia Palma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marzia Palma. Marzia Palma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kokhaei, Parviz, Ali Moshfegh, Jeanette Lundin, et al.. (2024). A Small Molecule Antagonist of CX3CR1 (KAND567) Inhibited the Tumor Growth-Promoting Effect of Monocytes in Chronic Lymphocytic Leukemia (CLL). Cancers. 16(22). 3821–3821. 3 indexed citations
2.
Hojjat‐Farsangi, Mohammad, Ann Svensson, Jeanette Lundin, et al.. (2023). A CX3CR1 (fractalkine receptor) Small Molecular Antagonist (KAND567) Suppressed the Growth Promoting Effect of Monocytes on Chronic Lymphocytic Leukemia Cells. Blood. 142(Supplement 1). 5716–5716. 1 indexed citations
3.
Andersson, Maria, Jinghua Wu, David Wullimann, et al.. (2023). Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia. Journal of Hematology. 12(4). 170–175. 3 indexed citations
5.
Fohlin, Helena, Gunilla Enblad, Bengt Glimelius, et al.. (2022). Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy. Journal of Clinical Oncology. 40(13). 1487–1496. 12 indexed citations
6.
Bogdanović, Gordana, Marcus Buggert, Yu Gao, et al.. (2021). Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients. Leukemia. 36(2). 476–481. 23 indexed citations
7.
Lundin, Jeanette, Tove Wästerlid, Håkan Mellstedt, et al.. (2021). Temporary cessation of ibrutinib results in reduced grade 3‐4 infections and durable remissions—Interim analysis of an on‐off‐repeat Phase 1b/2 study in patients with chronic lymphocytic leukemia. SHILAP Revista de lepidopterología. 2(3). 525–529. 1 indexed citations
8.
Palma, Marzia, et al.. (2021). BTK Inhibitors in Chronic Lymphocytic Leukemia: Biological Activity and Immune Effects. Frontiers in Immunology. 12. 686768–686768. 53 indexed citations
9.
Holte, Harald, Ingrid Glimelius, Magnus Björkholm, et al.. (2019). No excess long‐term mortality in stage I‐IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy. British Journal of Haematology. 188(5). 685–691. 18 indexed citations
10.
Wahlin, Björn E., et al.. (2019). Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application. Cancers. 11(7). 915–915. 25 indexed citations
11.
Björklund, Andreas T., Mattias Carlsten, Ebba Sohlberg, et al.. (2018). Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML. Clinical Cancer Research. 24(8). 1834–1844. 141 indexed citations
12.
Sarhan, Dhifaf, Marzia Palma, Yumeng Mao, et al.. (2015). Dendritic cell regulation of NK‐cell responses involves lymphotoxin‐α, IL‐12, and TGF‐β. European Journal of Immunology. 45(6). 1783–1793. 30 indexed citations
14.
Palma, Marzia, Anton Parker, Mohammad Hojjat‐Farsangi, et al.. (2013). Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia. Experimental Hematology. 41(7). 615–626. 13 indexed citations
15.
Giordano, Paola, Valerio Cecinati, Giancarlo Vecchio, et al.. (2011). Magnetic Resonance Imaging Screening of Cerebral Thromboembolic Events in Children with Acute Lymphoblastic Leukemia: A Pilot Study. Neuropediatrics. 42(2). 55–59. 2 indexed citations
16.
Adamson, Lars, Marzia Palma, A Choudhury, et al.. (2009). Generation of a Dendritic Cell‐based Vaccine in Chronic Lymphocytic Leukaemia Using CliniMACS Platform for Large‐scale Production. Scandinavian Journal of Immunology. 69(6). 529–536. 13 indexed citations
17.
Palma, Marzia, Lars Adamson, Lotta Hansson, et al.. (2008). Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia. Cancer Immunology Immunotherapy. 57(11). 1705–1710. 17 indexed citations
18.
19.
Ianari, Alessandra, Rita Gallo, Marzia Palma, Edoardo Alesse, & Alberto Gulino. (2004). Specific Role for p300/CREB-binding Protein-associated Factor Activity in E2F1 Stabilization in Response to DNA Damage. Journal of Biological Chemistry. 279(29). 30830–30835. 76 indexed citations
20.
Borgna‐Pignatti, Caterina, Antonio Piga, Simone Rugolotto, et al.. (1997). Survival and disease complications in thalassemia major. Bone Marrow Transplantation. 19. 16–17. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026